Pricing Log in Create free account

Jaguar Animal Health, Inc. (JAGX) vs Liminatus Pharma Inc. (LIMN)

Jaguar Animal Health, Inc. and Liminatus Pharma Inc. are both Biotechnology companies. Jaguar Animal Health, Inc. and Liminatus Pharma Inc. are of similar size ($4.2M and $4.2M). Liminatus Pharma Inc. has negative trailing earnings, so its P/E is not meaningful; Jaguar Animal Health, Inc. trades at 0.0×. Liminatus Pharma Inc. has the higher net margin (0.00% vs −188.5%) and the higher return on invested capital (0.00% vs −28,393.6%). Across the 13 metrics below, Liminatus Pharma Inc. leads on 8 and Jaguar Animal Health, Inc. on 5.

Valuation

Metric JAGX LIMN Biotechnology median
P/E 0.00 n/m 8.58
P/S 0.00 n/m 10.29
P/B 0.02 9.98 2.29
Price to free cash flow n/m n/m 21.93
EV/EBITDA 0.14 n/m 0.67
EV/Sales (0.11) n/m 9.89
Earnings yield 82,577.65% (758.06%) (31.56%)
Free cash flow yield (6,233.72%) (132.39%) (23.42%)

Profitability

Metric JAGX LIMN Biotechnology median
Gross margin 82.31% — 65.77%
Operating margin (93.10%) 0.00% 0.00%
Net margin (188.46%) 0.00% 0.00%
Free cash flow margin (24.03%) 0.00% 0.00%
Return on equity (1,125.38%) 294.43% (54.09%)
Return on assets (127.14%) (471.47%) (47.78%)
Return on invested capital (28,393.64%) 0.00% 0.00%

Growth

Metric JAGX LIMN Biotechnology median
Revenue growth (TTM) 135.52% — 5.83%
EPS growth (last fiscal year) 82.42% (112.19%) 29.36%
Revenue growth, 5-year CAGR 4.17% — 9.41%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric JAGX LIMN Biotechnology median
Debt to equity 0.35 4.80 0.00
Current ratio 0.69 1.12 4.80
Net debt to EBITDA (0.17) (0.37) 0.97

Dividend

Metric JAGX LIMN Biotechnology median
Dividend yield — — 0.44%
Payout ratio — — —

Size

Metric JAGX LIMN Biotechnology median
Market cap 4.18m 4.18m 153.35m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack